Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04539392
Other study ID # NIMAO/2019-2/SH-01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 28, 2022
Est. completion date June 2024

Study information

Verified date January 2024
Source Centre Hospitalier Universitaire de Nimes
Contact Stéphanie Huberlant
Phone 04.66.68.34.69
Email stephanie.huberlant@chu-nimes.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study hypothesis is that infertile couples experience an impact of their sexuality impacted during the diagnostic process carried out as part of the medically assisted procreation assessment, and also by the announcement of the possible cause of the couple's infertility. It is also conceivable that a disorder of the couple's sexuality forms the origin of, or is a contributor to, infertility.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 2024
Est. primary completion date June 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Couple in which each of the two partners has signed the consent form which is presented separately and independently of their partner. - The patient must be a member or beneficiary of a health insurance plan - Heterosexual infertile couple (according to the WHO definition) monitored at the Nîmes University Hospital in the urology / gynecology departments. Adult patient (=18 years old) and under 40 years old for women, 60 years old for men Exclusion Criteria: - The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study - One member of the couple refuses to sign the consent - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship - Patient without good level of written and spoken French

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaires on sexuality
Panel of questionnaires assessing sexuality, relationship satisfaction, and body image

Locations

Country Name City State
France CHU de Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sexuality of the female of the couple Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 2 weeks after inclusion (start of MAP)
Primary Sexuality of the female of the couple Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 1 month after ovarian ponction (end of MAP)
Primary Sexuality of the male of the couple Male Sexual Health Questionnaire 2 weeks after inclusion (start of MAP)
Primary Sexuality of the male of the couple Male Sexual Health Questionnaire 1 month after ovarian ponction (end of MAP)
Primary Ejactulation of the male of the couple Premature Ejaculation Profile 2 weeks after inclusion (start of MAP)
Primary Ejactulation of the male of the couple Premature Ejaculation Profile 1 month after ovarian ponction (end of MAP)
Secondary Sexuality of the female of the couple Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 1 month after ovarian ponction (end of MAP)
Secondary Sexuality of the male of the couple Male Sexual Health Questionnaire 1 month after ovarian ponction (end of MAP)
Secondary Body satisfaction and global self-perception of both members of the couple Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. 2 weeks after inclusion (start of MAP)
Secondary Body satisfaction and global self-perception of both members of the couple Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. 1 month after ovarian ponction (end of MAP)
Secondary Relationship satisfaction of both members of the couple Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 2 weeks after inclusion (start of MAP)
Secondary Relationship satisfaction of both members of the couple Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 1 month after ovarian ponction (end of MAP)
Secondary Self-esteem of both members of the couple Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. 2 weeks after inclusion (start of MAP)
Secondary Self-esteem of both members of the couple Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. 1 month after ovarian ponction (end of MAP)
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A